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Introduction: Although hypertension constitutes a major risk factor for cardiovascular   morbidity 
and mortality, research on adherence to antihypertensive treatment has shown that at least 75% 
of patients are not adherent because of the combined demographic,   organizational,   psychological, 
and disease- and medication-related factors. This study aimed to elicit   hypertensive patients’ 
beliefs on hypertension and antihypertensive treatment, and their role to adherence.
Methods: Transcripts from semistructured interviews and focus groups were content analyzed 
to extract participants’ beliefs about hypertension and antihypertensive treatment, and attitudes 
toward patient–physician and patient–pharmacist relationships.
Results: Hypertension was considered a very serious disease, responsible for stroke and 
myocardial infarction. Participants expressed concerns regarding the use of medicines and the 
adverse drug reactions. Previous experience with hypertension, fear of complications, system-
atic disease management, acceptance of hypertension as a chronic disease, incorporation of the 
role of the patient and a more personal relationship with the doctor facilitated adherence to the 
treatment. On the other hand, some patients discontinued treatment when they believed that 
they had controlled their blood pressure.
Conclusion: Cognitive and communication factors affect medication adherence. Results could 
be used to develop intervention techniques to improve medication adherence.
Keywords: hypertension, medication adherence, patient compliance, doctor–patient commu-
nication, antihypertensive medicine
Introduction
Nonadherence to treatment medication, especially in chronic diseases, is a   complicated 
issue affecting patients’ health, health expenditure, and recourses’ utilization.1,2 
A   number of studies, both qualitative and quantitative, examine the factors that are 
believed to explain variations in adherence in other chronic diseases.3–5 Based on such 
findings, interventions have been designed to improve patient compliance.6
Research on health behaviors, such as medication adherence, has resulted in 
the formulation of specific psychological theories addressing patients’ beliefs and 
roles. Leventhal and colleagues’ Self-Regulatory Model (SRM)7 suggests that when 
individuals face a health threat, they form both cognitive and emotional representations 
of the disease, which act in parallel to influence associated health behaviors. Cognitive 
representations comprise of beliefs on illness identity, antecedent causes, consequences, 
timeline, and cure-control,8 whereas the emotional representations comprise individual’s 
emotional reaction to the disease. Furthermore, individual’s beliefs about treatment have 
been proposed as another determinant to understand the way in which patients make Patient Preference and Adherence 2010:4 submit your manuscript | www.dovepress.com
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decisions about their treatment.9 Finally, different aspects 
of doctor–patient communication have been examined as 
potential predictors of medication adherence.10
Hypertension is the medical condition where the 
  systolic blood pressure is more than 140 mm Hg and the 
diastolic blood pressure is more than 90 mm Hg.11 It is a 
chronic disease which is considered to be one of the major 
public health problems and a significant cardiovascular risk 
factor. According to the World Health Organization (WHO), 
each year, at least 7.1 million people die as a result of 
increased blood pressure.12 For the treatment of hypertension, 
a broad range of antihypertensive medications are currently 
available, as well as Therapeutic Lifestyle Changes such as 
weight reduction, increased physical activity, and reduction 
of dietary salt intake, which have proven to be important 
in disease management.13 Although there is evidence that 
increased blood pressure can actually be controlled with 
the cardiovascular risk factor being thus reduced,14 75% of 
patients diagnosed with hypertension cannot achieve full 
control of their blood pressure.13 Poor blood pressure con-
trol is associated with higher healthcare resource utilization 
and costs15 and increased risk of cardiovascular diseases. 
Nonadherence to antihypertensive medication is the main 
reason for failure to control blood pressure among those 
under treatment.16
In Greece, although there is no nationwide data available 
for the prevalence of hypertension, it is estimated that 25% 
of the adult population are suffering from it.11 Moreover, it 
is estimated that 40% of hypertensive adults are unaware 
of their condition, and 25% of those receiving treatment do 
not succeed in controling their blood pressure.11 Other stud-
ies have shown that awareness and control of hypertension 
and blood pressure is lower in Greece compared with other 
countries.17,18
In addition, few studies have been conducted in Greece 
investigating the issue of adherence to treatment. The aim 
of the present study was to investigate the factors affecting 
antihypertensive medication adherence in Greece.
Methods
study design
Semistructured interviews and focus groups were conducted 
in order to elicit data from people with hypertension. 
Semistructured interviews were preferred for those attending 
the Hypertension Centers (HCs) (Group A), allowing the inves-
tigators to approach them individually, as HC attendees were 
of older age. Older age is related to sensory loss that interferes 
with reception of the spoken message. People with sensory 
loss thus frequently experience communication problems.19 
One-to-one semistructured interviews could overcome this 
problem, which might otherwise influence older age partici-
pants’ ability to participate effectively in focus groups. Focus 
groups were preferred for the group of younger participants 
(Group B), aged between 40 and 50 years, who were not or 
usually were not attending the HC, suffer from sensory loss. 
The age criterion was based on the available data regarding 
hypertension prevalence in Greece.20 According to these 
data, diagnosed hypertensive patients younger than the age 
of 40 years represent less than 1.6% of the total number of 
hypertensive patients. Although it would be really hard for 
these patients to be identified, we decided to have this age 
criterion of hypertensive patients older than 30 years in case 
we could not find anyone between the ages of 30–40 years. 
In the case of focus groups, the lower limit was increased, 
from 30 to 40 years of age, because it was impossible for us 
to identify hypertensive patients between the ages of 30–40 
years among the registered hypertensive patients. Fieldwork 
was conducted during the period May–July 2008.
Participants and settings
Group A participants were recruited from HC established 
in hospitals of the greater Athens area. Three HCs were 
purposively selected in order to reflect different geographic 
and socioeconomic regions. Two were established in public 
hospitals, and the third was established in an insurance fund 
hospital. In each center, the physician in charge assisted 
researchers to recruit patients.
Participants had to meet the following inclusion criteria in 
order to participate in the study: (a) being aged above 30 years, 
(b) receiving antihypertensive treatment for at least 1 year, 
and (c) speaking the Greek language fluently.
When patients who met the inclusion criteria attended 
the HC, on a specific day, an invitation letter was given 
to them by their physician explaining the purpose and the 
methodology of the study. In total, 25 patients accepted to be 
interviewed. Interviews were conducted, immediately after 
patients’ medical examination in a private room in the HC, 
provided for the purposes of this study.
All interviews were facilitated by two researchers 
(psychologist [PP] and co-moderator [VT]). All interviews 
were anonymous and were audio taped, after participants’ 
consent.
For Group B participants, the inclusion criteria were as 
follows: (a) being aged between 40 and 50 years, (b) receiving 
antihypertensive treatment for at least 1 year, (c) not consult-
ing an HC, and (d) speaking the Greek   language fluently.Patient Preference and Adherence 2010:4 submit your manuscript | www.dovepress.com
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Recruitment for Group B participants was made with 
convenience and purposive sampling. A telephone invitation 
survey among 200 registered hypertensive patients was 
conducted in order to identify those who met the inclusion 
criteria and were willing to attend the focus group sessions. 
In total, 18 patients (50% female) accepted to participate. 
Similar to semistructured interviews, participants were 
informed about the aims of the study, the methodology, and 
were assured of anonymity and confidentiality.
Two focus groups were organized, one comprising of 
9 males and the other comprising of 9 females, in order to 
facilitate group dynamics and achieve higher homogeneity.21 
Each group was moderated by an experienced psychologist 
and a co-moderator whose primary responsibility was to 
take notes during sessions. Both researchers met after each 
session in order to assess the procedure and identify crucial 
elements for the interpretation of the data.
Focus groups took place at the Department of Health 
Economics, National School of Public Health in Athens. 
The first session had a duration of 2 hours 8 minutes and the 
second 2 hours 22 minutes. Comfortable chairs, beverages, 
and snacks were offered in order to create a pleasant 
atmosphere and lighten the burden of the long duration of 
the focus group. Focus group sessions were tape-recorded, 
after participants’ written consent.
content and questions
According to standard methodology, open-ended questions 
and probes were predetermined for use during the semistructured 
interviews and the focus groups. These were based on the 
review of the relevant literature, taking into consideration the 
recommendations of the research team. Questions and probes 
fell within four research topics (see Table 1):   perceptions and 
beliefs about hypertension, perceptions and beliefs toward 
antihypertensive treatment, patient—physician   relationship, 
and patient—pharmacist relationship. Commencing ques-
tions in each research topic were general, capturing par-
ticipants’ beliefs in hypertension and treatment. Probes were 
more   specific in order to elicit the opinion, experience, and 
  behavior of the participant. Only demographic information 
was   collected by a purpose-made short questionnaire.
Analysis
All interviews and focus group recordings, as well as notes 
kept by the focus group co-moderator, during the   sessions 
were fully transcribed. Transcriptions were analyzed using 
content analysis,22 without using any qualitative data 
  software. Each researcher (PP and VT) separately studied 
the transcriptions and the notes kept by the co-moderator, 
identified the emergent themes and keywords, and categorized 
the findings according to the four research topics. Then, the 
research team met in order to compare the findings, interpret 
results, and formulate conclusions. Demographic data were 
analyzed using MS Excel 2007.
Results
Group A comprised of 25 participants aged between 47 and 
79 years (mean age, 63.7 years), whereas the 18 participants 
in Group B were aged between 40 and 50 years (mean age, 
44.6 years; Table 2). Participants did not differ significantly 
in relation to gender. Group A participants were more likely 
(84%) to be under medication treatment for co-morbidities 
than their Group B counterparts (66.7%); however, this 
difference did not reach statistical significance.
Perceptions and beliefs  
about hypertension
Hypertension was considered a very serious disease 
  responsible for even more dangerous medical conditions such 
Table 2 Demographic characteristics of the participants
Characteristics Semistructured  
interviews (Group A) 
N = 25
Focus groups   
(Group B) 
N = 18
Mean, N (%) Mean, N (%)
gender
  Male 12 (48%) 9 (50%)
  Female 13 (52%) 9 (50%)
Age (mean) 63.7 44.6
no. of patients receiving  
additional medication for  
other conditions
21 (84%) 12 (66.7%)
Table 1 Topics and subtopics of the qualitative study
No Main topics Subtopics
1 Perceptions: beliefs  
about hypertension
• risk factors 
• complications 
• sources of information 
• symptoms and disease diagnosis
2 Perceptions: beliefs  
about antihypertensive  
treatment
•   Attitudes and beliefs towards  
drugs in general
• Adverse drug reactions 
•   Factors influencing adherence to   
antihypertensive treatment
• Adherent characteristics
3 Patient–physician  
relationship
4 Patient–pharmacist  
relationship
•   Dispensing/recommending  
medicationsPatient Preference and Adherence 2010:4 submit your manuscript | www.dovepress.com
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as stroke and myocardial infarction. Stress, anxiety, limited 
physical activity, and unhealthy diet emerged as the perceived 
most important risk factors of hypertension.
•	 “Hypertension has very serious consequences, you can 
have a stroke … it is very bad”. (Group A, female)
•	 “… Cardiovascular diseases and death. This is what I am 
thinking when I hear hypertension. If you don’t control 
it you will die”. (Group B, female)
•	 “I believe that stress is the major factor that makes all 
of us or at least most of us suffering from hypertension” 
(Group B, male)
•	 “It is not only stress, but the way of life in general”. 
(Group B, male)
sources of information
The main sources of information were the physician or the 
pharmacist, the media, the Internet, and people who suffered 
from hypertension. However, participants admitted that their 
physician was the most trusted source. Participants were 
interested in further information for two reasons: to achieve 
a better understanding of their doctor’s advice and to check 
the validity of this advice.
•	 “My doctor gave me some information, but I search 
information through Internet too, so I can cross-check 
what he says”. (Group A, male)
•	 “… mainly my doctor and some books. But usually I talk 
with people who also suffer from hypertension, I feel 
more comfortable discussing with them” (Group A, 
female)
•	 “There are TV programs about health, but I always 
discuss everything I hear with my doctor” (Group B, 
male)
symptoms and disease diagnosis
Although hypertension was associated with well-recognized 
symptoms, such as headaches and dizziness, participants 
often did not seek health care, at least until those symptoms 
became unbearable.
•	 “I knew that I had high blood pressure but I had never 
gone to a doctor, until I couldn’t bear the pain of the 
headaches” (Group A, male)
•	 “I was feeling a constant pressure in my head, so I decided 
to consult a doctor …” (Group B, female)
When symptoms were mild, participants were usually 
referring to a pharmacist. If symptoms were more intense, 
they were looking for a specialist mainly an internist or a 
cardiologist.
•	 “I was not feeling well, so I went to a pharmacist to 
measure my blood pressure …” (Group B, female)
•	 “One day, I felt very strange, like having a heart attack 
or stroke; I was so scared that I went to the hospital …” 
(Group B, male)
•	 “I had strong headaches and because my father had 
also hypertension, I went to a cardiologist” (Group A, 
female)
Participants’ perceptions and beliefs 
toward antihypertensive treatment
Attitudes and beliefs towards drugs
Concerns and fear were expressed by the majority of 
participants regarding the use of medicines. Some of them 
expressed the opinion that the long-term use of medicines 
will have an impact on their immune system.
•	 “In general, I avoid taking medicines. If the decision is 
on me I will not take any drugs …” (Group A, male)
•	 “… Some years ago I was suffering from spondylolisthesis 
and my doctor prescribed anti-inflammatory, and then my 
blood pressure was 18 to 19”. (Group A, female)
•	 “… I have taken so many drugs that I have destroyed my 
immune system …” (Group A, female)
•	 “… I don’t like it (taking drugs) at all, because you try 
to fix one thing and something else goes wrong …” 
(Group A, female)
•	 “Yes, but so many drugs? Don’t all of these end up in the 
liver? For how long can it (the liver) bear all these? … 
and it is only one. I don’t know, I am a little afraid”. 
(Group B, female)
Adverse drug reactions
Adverse drug reactions were an issue of great concern for 
the majority of study participants. Some of them had stopped 
their treatment because they were afraid of the possible 
side effects. Avoidance of getting to know the possible side 
effects was also one of the reasons given for not reading the 
information leaflet of the drug.
•	 “… If I read (in the leaflet) that the drug has adverse 
drug reactions and this or that can happen to me, I stop 
the treatment …” (Group A, male)
•	 “If you read about side effects you should not take any 
medicine. However, I have prevented some reactions 
because I had read the information leaflet” (Group A, 
male)
•	 “I don’t read the side effects, because then I think that I 
suffer from all these reactions” (Group B, female)Patient Preference and Adherence 2010:4 submit your manuscript | www.dovepress.com
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•	 “I usually read the side effects, but I can’t understand 
everything … I trust my doctor who prescribes it. If 
something goes wrong I believe that I will understand 
it” (Group B, male)
Factors influencing adherence  
to antihypertensive treatment
The level of adherence among participants ranged. Previous 
experiences regarding hypertension and the fear or 
knowledge that they could suffer from a complication if they 
did not control their blood pressure were important reasons 
for medication adherence.
•	 “I didn’t know what it means to have high blood pressure 
for years and what this can cause to you …” (Group A, 
male)
•	 “… because I have read and I know what can   happen 
to me if I do not follow the treatment” (Group A, 
female)
•	 “… I take the pill every day, because I am afraid” (Group 
B, female)
•	 “… my neighbor had a stroke 5 years ago and he hasn’t 
recovered yet. I see all these and I follow my treatment 
because I am afraid that this will happen to me too”. 
(Group B, male)
•	 “… I am afraid of what will happen to me because of 
the hypertension, there is also the heredity”. (Group B, 
male)
In addition, systematic disease management, especially 
in HC, was a significant factor influencing treatment 
adherence.
•	 “Here (in the HC) I have a program and I come regularly 
for my blood pressure …” (Group A, male)
•	 “First of all, it is very important that I come here   regularly 
and I have a program, an antihypertensive program, 
and since I’ve started taken my pills nothing has gone 
wrong …” (Group A, male)
Another important factor affecting adherence was the 
acceptance of the disease and the adoption of the patient’s 
role. Most of the participants, especially the younger ones 
who participated in focus groups, were hesitant and negative 
to the idea of taking a medicine for their whole life. The 
sooner they perceived hypertension as a chronic disease, the 
more adherent they became.
•	 “… at first I was really stressed. I didn’t want to believe 
that I will receive an antihypertensive treatment, why 
me? I was feeling really sad, it was like killing me …” 
(Group B, male)
•	 “I believe that it is tragic to take a medication for the 
whole of your life, I can’t stand it. I believe that it is 
the beginning of the end, the beginning of taking more 
drugs …” (Group B, male)
Sometimes, acceptance of the disease led to the change 
of patient’s lifestyle.
•	 “… after this (the diagnosis of hypertension) the whole 
perspective about my diet changed …” (Group B, 
male)
Adherence characteristics
Adherence to treatment was easier if the medication 
were received in the morning. In this case, the majority 
of participants had associated their medication with their 
breakfast or had invented different tricks in order to 
remember it.
•	 “I take it during breakfast, I am used to it now” (Group A, 
female)
•	 “I take it every morning, I set the alarm clock in order 
to remember it, you have to associate it with something, 
otherwise you forget it” (Group B, male)
Most of the participants admitted during weekends 
they received their medication some hours later than the 
appropriate, believing that this was an “innocent” tactic, 
although their doctor had warned them for the opposite.
•	 “At the weekends I take my pill 3 hours later … 
I don’t believe it does any harm. On the contrary, three 
hours more sleep is good because our organism is calm 
when we are sleeping. When we wake up we need the 
pill …” (Group B, female)
The drug substance also seemed to be an important factor 
affecting adherence when its effects interferes with patients’ 
activities.
•	 “I take one pill every morning. But, because it is diuretic, 
when I go out I do not take it …” (Group A, male)
Finally, some of the participants mentioned that they 
stopped the treatment from time-to-time when they no longer 
suffered from symptoms or when they believed that they had 
controlled their blood pressure.
•	 “If my blood pressure is at good levels, I can’t see the 
reason to take it (the pill). I am afraid to take it because 
it might cause hypotension to me”. (Group A, female)
•	 “… When I have symptoms I follow my treatment, when 
I feel good I don’t ….” (Group B, female)
•	 “I stopped the treatment for a period, just to see what 
will happen, if I will get better … but it didn’t work” 
(Group B, male)Patient Preference and Adherence 2010:4 submit your manuscript | www.dovepress.com
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Patient–physician relationship
The majority of participants considered the relationship 
with their physician of great importance. Good atmosphere 
during consultation and physician’s time spent on giving 
advice and answering questions were mentioned as the most 
important characteristics of a “good” doctor. Distant and 
formal behavior of physician could be a reason for changing 
the doctor for some participants.
•	 “I appreciate my doctor very much, he explains 
everything to me. He doesn’t care only about prescribing. 
He practices real medicine. (Group A, male)
•	 “First of all they really seem to care about me. They 
listen to my questions and wishes and I understand it” 
(Group A, male)
•	 “I stopped consulting my first doctor because of his 
behavior. I don’t know, this was probably because of 
his age, he was old, but the distance between me and 
the physician was big. I wanted to ask something and I 
hesitated, and when I did so his answers were yes or no, 
nothing more ….” (Group B, female)
Good communication and a rewarding behavior of the 
physician as well as a high level of confidence also seemed 
to facilitate adherence.
•	 “If I have good results, then my doctor congratulates me” 
(Group A, female)
•	 “I believe that the doctor should inspire you confidence, 
then you will follow the treatment and if the doctor is 
strict you will comply ….” (Group A, female)
•	 “I feel gratitude; the whole team here works for me”. 
(Group A, male)
Patient–pharmacist relationship
Regarding patient–pharmacist relationship, participants 
trusted their pharmacist’s advice on taking the appropriate 
medication when they concerned a minor health condition 
such as a sore throat or a cold. For more serious conditions 
such as hypertension, they trusted only their physician for 
prescribing a drug. Still, participants consult their pharmacist 
for additional information on treatment, such as whether they 
should take the drug before or after dinner.
•	 “… I don’t want to take medicines if my doctor hasn’t 
prescribed them …” (Group A, female)
•	 “(I trust the pharmacist) … for simple things like throat, 
nose and things like these. For more serious conditions I 
consult the doctor …” (Group A, male)
•	 “I could trust my pharmacist for something simple like 
a sore throat. In that case I could consult the pharmacist 
instead of the physician” (Group B, male)
•	 “I will ask the pharmacist for additional information, for 
example if I should take my medication before or after 
dinner, things like that” (Group A, male)
•	 “… the pharmacist is not a doctor. The pharmacist sells 
drugs” (Group B, female)
Participants from the insurance fund HC referred to drug 
cost as another reason for not seeking pharmacist’s advice 
on taking the appropriate medication.
•	 “… These are expensive (the antihypertensive drugs). 
How can I pay for these without a prescription? I am a 
pensioner and my pension is low” (Group A, female)
•	 “… my doctor has prescribed all the drugs I take … I can’t 
take it without a prescription, I am a pensioner and … 
you understand …” (Group A, female)
Discussion
Research on the adherence of antihypertensive treatment has 
shown that patient’s nonadherence to medication is related 
with a mix of demographic, organizational, psychological, 
and disease- and medication-related variables.23,24 Thus, 
investigating patients’ beliefs regarding hypertension itself 
and antihypertensive treatment, as well as communication 
factors that affect adherence, can have a great impact 
on designing effective interventions in order to improve 
treatment adherence.
The present study is the first in Greece, which examined 
hypertensive patients’ beliefs about hypertension and 
antihypertensive medicines, as well as patients’ behaviors 
concerning treatment adherence. It also examined patient–
doctor relationship and its impact on adherence. Finally, the 
study examined patients’ beliefs about the role of pharma-
cists. In general, results are consistent with findings from 
other qualitative studies on antihypertensive medication 
adherence.25,26
The majority of participants considered hypertension as 
a very serious disease and were afraid and anxious about 
potential serious consequences on their health in case of 
failure to manage the disease. These negative feelings toward 
hypertension represent a finding that differs from those of 
other studies, where hypertension was found to be considered 
a less important disease with well-recognized symptoms.23 
Further research based on theoretical models like SRM is 
required so that Greek patients’ beliefs about hypertension 
is further explored.
Stress emerged as one of the main risk factors of hyperten-
sion. Even though participants acknowledged the importance 
of this factor, stress was believed to be inevitable, and this 
situation was attributed to the modern way of living.Patient Preference and Adherence 2010:4 submit your manuscript | www.dovepress.com
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Participants were being informed about hypertension 
from a plethora of sources, but they trusted mainly their 
physician. Furthermore, they were feeling comfortable 
to discuss about hypertension with other hypertensive 
patients. This finding was also confirmed during the focus 
group sessions where participants were interested in sharing 
their experiences and discussing their health problem with 
each other.
Participants reported that they attend different health 
care facilities depending on the severity of symptoms. 
This behavior reflects the characteristics of the health care 
system in Greece and the way it is organized. In the absence 
of   integrated primary care with a gate-keeping system, 
patients seek care and advice of the pharmacists when it 
concerns minor health conditions while they face limited 
or no barriers at all in accessing and choosing health care 
providers. This enables them to visit a specialist as often as 
they wish without referral from a general practitioner.
Based on the results of our study, the factors that 
influence medication adherence concern the management 
of the disease, the treatment characteristics, and the patient–
physician relationship. The systematic   disease management 
includes regular appointments with the physician and 
intense counseling in order for the patient to be aware 
of the complications of uncontrolled blood pressure. 
  Treatment characteristics, such as the time of receiving the 
medicine, the number of doses, and the drug substance, 
were reported as influential factors. These characteristics, 
which may be considered minor, are really important for 
patient compliance and have been identified in other studies 
as well.23,25–27
Although an association between adherence and 
demographic characteristics such as age and gender could 
not be established due to the nature of the study, it seems 
that younger adults in Greece face greater difficulty in 
the acceptance of the disease and consequently in adher-
ing to treatment. Age-related illness perception, with the 
elderly being more adherent, has also been reported in 
other studies.27 Building on the results of the present study, 
a longitudinal quantitative survey would be useful in order 
to further explore – confirm or reject – the aforementioned 
finding.
Results suggest that the major factor affecting positive 
medication adherence is a good doctor–patient relation-
ship. A physician who encourages and rewards patients, and 
most importantly, spends quality time with them in giving 
information and providing explanations about the disease and 
treatment contributes significantly in patients’ compliance. 
This finding is consistent with a number of previous studies that 
have established the importance of this relationship.23,25,26
In contrast, pharmacist–patient relationship seems that 
it did not affect medication adherence among study partici-
pants. However, a finding worthwhile to be further researched 
is the role of cost of drugs in adherence because this was 
a matter of great concern for a number of participants, 
especially those attending insurance funds HC. Cost and 
particularly level of co-payment has been identified as an 
important factor   associated with adherence to   pharmaceutical 
treatment.28
Perceptions of personal risk and outcome expectancies, as 
well as redefinition of self concept or social role, have been 
proven to create a “teachable moment” for risk-reducing 
health behaviors.29,30 In our study, participants do create a 
“teachable moment” about hypertension, by cognitively 
escalating the severity of their symptoms. Previous experi-
ences regarding hypertension, either personal or those of 
friends and family, and knowledge about the complications of 
the disease were major determinants of a teachable moment. 
Nevertheless, due to organizational factors, participants 
seem to adopt a risk-reducing health behavior (ie, visit an 
HC) only at a very late stage. A primary intervention stage 
should be identified, and early prevention strategies should 
be adopted so that hypertensive patients benefit at an earlier 
prohypertension stage rather than waiting until they are 
diagnosed with hypertension.
Limitations
All participants of the present study reported adherence 
to treatment at the time of the study, a finding initially 
  indicating high levels of adherence in Greek hypertensive 
patients compared with previous studies conducted in 
Greece.20 Nevertheless, participants mentioned that they did 
not take medication at the right time, or skipped if they felt 
well,   indicating a rather nonadherent than adherent pattern 
of behavior. This inconsistency perhaps shows a cognitive 
bias, which underline causes worth further   investigation. 
  Psychological factors like patients’ frustration due to ineffi-
cient   antihypertensive treatment or the meaning of monitoring 
blood pressure at home or telemonitoring might have some 
effects on adherence. Furthermore, the detected inconsistency 
could represent a time-related reference: participants referred 
to all these behaviors regarding their pharmaceutical treat-
ment, considering them as past behaviors and not things that 
they usually do in the present. In addition, this result may 
only be due to a volunteer effect and can be considered a 
methodological limitation given that, according to literature, Patient Preference and Adherence 2010:4 submit your manuscript | www.dovepress.com
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adherence to antihypertensive treatment ranges between 50% 
and 70%.13 Unanimous adherence allowed the identification 
of the factors contributing to adherence but prevented us 
from exploring the factors that inhibit it (although it could 
well be assumed that the opposite factors can be responsible 
for nonadherence).
From a methodological point of view, the smaller num-
ber of participants interviewed in HC, three compared to 
the number of participants in the other two HCs, could be 
considered another limitation of the study. However, due to 
the qualitative methodology adopted and the fact that direct 
comparisons among HCs were not an objective of the study, 
this sample difference has a limited effect on results.
Finally, the long duration of the focus groups may be 
considered another limitation of the study. Although we took 
care to achieve a comfortable environment for participants, 
it is not quite sure whether they were fully engaging in the 
end of the discussion.
Conclusion
In conclusion, the present study confirmed that cognitive and 
communication factors—patients who were better informed, 
had previous experiences of the disease, and a good rela-
tionship and communication with their physician—were 
important determinants for adherence. These results could 
form the basis for designing effective interventions adjusted 
to the Greek reality aiming at both enhancing doctor–patient 
communication and empowering the patient himself. Such 
interventions have the potential to improve the adherence 
of hypertensive patients’ medication and can consequently 
reduce hypertension-related costs.
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